The Involvement of Cortical Inhibition, Plasticity, and Excitability in the Neurobiology and Treatment of Late-Life Depression
Year: 2021
Type: dissertation
Abstract: Several lines of evidence indicate that the pathophysiology of depression includes altered inhibitory and excitatory neurotransmission in the cortex. Most studies to date, however, have focused on younger and mid-life adults with depression. Advancing age has widespread effects on the structure and function of the brain, and late-life depression is often characterized by unique clinical features, including executive dysfunction and high relapse rates. Thus, the pathophysiology of depression may differ in older adults. This work aimed to uncover how neurophysiological mechanisms driven by inhibitory and excitatory neurotransmission are involved in the pathophysiology and treatment of late-life depression. We combined single-pulse and paired-pulse transcranial magnetic stimulation (TMS) with electromyography to measure inhibition, plasticity, and excitability in the motor cortex of older adults with depression. TMS measures were collected prior to treatment initiation, and after 1 week and 12 weeks of treatment with venlafaxine. We also measured cognitive functioning pre-treatment, and depressive symptom severity pre- and post-treatment. We hypothesized that TMS measures would be abnormal in older adults with depression compared to healthy controls, and that these TMS measures would be associated with executive dysfunction and treatment outcomes in late-life depression. First, compared to younger healthy controls, we observed similar reductions in GABAA receptor-mediated cortical inhibition in older and younger adults with depression, and older healthy controls, suggesting overlapping cortical inhibition deficits in advancing age and depression across the lifespan. Second, we found a specific relationship between worse executive function and heightened cortical plasticity in older adults with depression. Third, cortical inhibition and plasticity were not found to change after 1 or 12 weeks of venlafaxine treatment, regardless of clinical response to treatment, suggesting that conventional pharmacotherapy may not target abnormalities in these motor cortical processes in late-life depression. Lastly, we demonstrated that pre-treatment single-pulse TMS measures of cortical excitability were predictive of response and non-response to venlafaxine treatment. Together, these findings highlight the importance of biological aging to the neurobiology of late-life depression, and clarify the unique roles that cortical inhibition, plasticity, and excitability each play in late-life depression pathophysiology, cognitive functioning, and treatment outcomes.
Source: TSpace (University of Toronto)
Author: Lissemore, Jennifer Inayat
Institution: University of Toronto
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7066767412
